Welcome to the international HTA database

Showing [20542 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2009	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Curative treatment for esophageal cancer: systematic review of neoadjuvant therapy and chemoradiotherapy alone: summary]
2008	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[CT scans for concussion]
2020	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[CT or MRT diagnostics for suspected chronic coronary heart disease: an evidence mapping]
2012	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[CT coronary angiography versus conventional invasive coronary angiography in CHD]
2011	Finnish Office for Health Care Technology Assessment (Finohta)	[CT colonography as a diagnostic method in colonic diseases]
2010	Committee for New Health Technology Assessment (CNHTA)	[Cryostripping]
2012	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cryopreservation of parathyroid glands for deferred autologous transplant in the management of hyperparathyroidism with surgical indication]
2022	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cryopreservation of eggs and sperm in patients initiating cancer therapy that may affect fertility]
2014	Basque Office for Health Technology Assessment (OSTEBA)	[Cryoablation in atrial fibrillation with Arctic Front catheter]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cryoablation for the treatment of persistent or symptomatic paroxysmal atrial fibrillation]
2006	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Cross-sectorial cooperation between general practice and hospital - shared care elucidated using anticoagulant therapy as an example - a health technology assessment]
2016	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Crizotinib: addendum to commission A15-59]
2016	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Crizotinib (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Crizotinib (new therapeutic indication) - Benefit assessment according to §35a SGB V]
2016	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Crizotinib (lung cancer) - Benefit assessment according to §35a Social Code Book V]
2013	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Crizotinib - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2021	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Crizanlizumab (sickle cell disease) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Criteria for indication and surgical treatment in Parkinson´s disease and epilepsy]
2011	Norwegian Knowledge Centre for the Health Services (NOKC)	[Criteria for assessment of the effect of preventive interventions]
2021	Institute for Clinical Effectiveness and Health Policy (IECS)	[COVID-19: follow-up after an acute episode]
2013	Belgian Health Care Knowledge Centre (KCE)	[Coupling of the permanent sample with the hospital data: feasibility and data representativeness study]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Costs and effects of two modes for disease management of chronic obstructive pulmonary disease (COPD) in general practice. A randomized controlled trial comparing regular nurse practitioner review and self-management education]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Costs and effects of strategies to prevent oversedation in intensive care patients]
2013	National Evidence-based Healthcare Collaborating Agency (NECA)	[Costing methods in healthcare]
2010	Belgian Health Care Knowledge Centre (KCE)	[Cost-utility of vaccination against chickenpox in children and against herpes zoster in elderly in Belgium]
2011	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Cost-utility analysis of the introduction of universal infant rotavirus vaccination in Spain]
2010	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Cost-utility analysis of pharmacological treatments for the prevention of bone fractures in osteoporotic post-menopausal Spanish women]
2020	Canary Health Service	[Cost-effectiveness of universal childhood vaccination against hepatitis A (update)]
2012	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of two strategies to implement the NVOG guidelines on hypertension in pregnancy: an innovative strategy including a computerised decision support system compared to a common strategy of professional audit & feedback]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of two different strategies to implement the NVOG guideline programme on subfertility]
2012	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of the demands and capacities model based treatment compared to the Lidcombe programme of early stuttering intervention: randomised trial]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of the Australian medical sheepskin for the prevention of pressure ulcers in somatic nursing home clients]
2006	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of selecting compatible donor blood in Rhc- and RhE negative females during and before reproductive age to prevent hemolytic disease in the newborn (HDN)]
2014	Basque Office for Health Technology Assessment (OSTEBA)	[Cost-effectiveness of percutaneous aortic valve replacement using prosthetic valve versus the standard surgical treatment]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of nutritional screening and intervention in elderly subjects after hip fracture]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of monitoring of psychotherapeutic treatments: a randomized comparison on the effects of feedback to therapists and patients in three settings of outpatient psychotherapy]
2019	Canary Health Service	[Cost-effectiveness of mechanical thrombectomy for treatment of ischaemic stroke]
2013	National Evidence-based Healthcare Collaborating Agency (NECA)	[Cost-effectiveness of human papillomavirus vaccination in South Korea]
2008	Center for Medical Technology Assessment (CMT)	[Cost-effectiveness of hearing aids - linear vs non-linear characteristics]
2006	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of follow-up of patients with superficial bladder cancer]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of different strategies for the treatment and monitoring of ocular hypertension and glaucoma]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of decision rules for the use of CT for minimal head injury]
2014	National Evidence-based Healthcare Collaborating Agency (NECA)	[Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in South Korea]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of cognitive behaviour therapy for recent onset schizophrenia patients with persistent and recurrent psychosis]
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[Cost-effectiveness of childhood vaccination against rotavirus in Norway]
2010	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of care for patients with type 2 diabetes, an evaluation of an innovative shared diabetes care model ("Ketenzorg model")]
2007	Center for Medical Technology Assessment (CMT)	[Cost-effectiveness of assistive technologies - walkers]
2001	Basque Office for Health Technology Assessment (OSTEBA)	[Cost-effectiveness analysis of treatments of sleep apnea syndrome in the Basque Country]
2008	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Cost-effectiveness analysis of population screening tests for colorectal cancer: systematic review of the efficacy and safety]
2006	Canary Health Service	[Cost-effectiveness analysis of colorectal cancer screening in general population]
2006	Canary Health Service	[Cost-effectiveness analysis of breast cancer screening]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Cost-effectiveness analysis of a telemonitoring experiment in patients with cardiac insufficiency and chronic obstructive pulmonary disease]
2010	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Cost-benefits evaluation of prevention and control of nosocomial MRSA infections]
2011	Health Intervention and Technology Assessment Program (HITAP)	[Cost-benefit analysis of prenatal screening and diagnosis for Down syndrome in Thailand]
2015	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Cost studies of type 2 diabetes: a review of literature]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Cost evaluation of the early breast cancer detection programme of the Autonomous Community of the Basque Country]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost effectiveness of two different implementation procedures to change clinicians practice roles in the detection of hereditary colorectal cancer]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost effectiveness of scalp cooling in the prevention of chemotherapy-induced hair loss]
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Cost effectiveness of different types of coronary stents which are used in patients with acute coronary syndrome (ACS)]
2022	Gesundheit Osterreich GmbH (GOeG)	[Cost effectiveness of communication training for health care professionals]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost effectiveness of a collaborative stepped care intervention for anxiety disorders in the primary care setting]
2015	Basque Office for Health Technology Assessment (OSTEBA)	[Cost effective analysis of negative pressure wound therapy for the treatment of venous ulcers in legs]
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Cost and budget impact analysis of an increase in day surgery for selected indications]
2008	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis]
2007	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis]
2013	Basque Office for Health Technology Assessment (OSTEBA)	[CORREX® aortic valve bypass for treatment of severe aortic stenosis]
2021	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Coronary lithoplasty for coronary heart disease - Assessment according to §137h Social Code Book V]
2021	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Coronary lithoplasty for coronary heart disease - Addendum to commission H20-07]
2022	Institute for Clinical Effectiveness and Health Policy (IECS)	[Coronary intravascular lithotripsy in coronary artery disease]
2001	Finnish Office for Health Care Technology Assessment (Finohta)	[Coronary angioplasty in Finland: an overview of the situation in 2000 and an estimation of needs in the near future]
2009	Committee for New Health Technology Assessment (CNHTA)	[Corneal cross linking]
2022	Institute for Clinical Effectiveness and Health Policy (IECS)	[Corneal collagen crosslinking with riboflavin in keratoconus]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Corneal collagen crosslinking with riboflavin for keratoconus patients]
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Corneal collagen crosslinking for keratoconus patients]
2015	Haute Autorite de sante (HAS)	[Corneal collagen cross-linking and intrastromal corneal ring segments in the treatment of corneal ectasia]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Corifollitropin alfa (Elonva®) for controlled ovarian stimulation in assisted human reproductive techniques]
2021	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Coping strategies in complex medical situations - the example of coronary heart disease]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Conventional Or Magnetic resonance angiography after Endovascular Treatment of intracranial aneurysms (COMET)]
2019	Basque Office for Health Technology Assessment (OSTEBA)	[Controlled and uncontrolled donation after circulatory death with regional normothermic or hypothermic perfusion based on extracorporeal membrane oxygenation for kidney and liver transplants]
2011	Finnish Office for Health Care Technology Assessment (Finohta)	[Continuous wound infusion of local anaesthetic agents for postoperative analgesia]
2012	Finnish Office for Health Care Technology Assessment (Finohta)	[Continuous subcutaneous insulin infusion in type 1 diabetes mellitus]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Continuous subcutaneous infusion pump for diabetic patients]
2013	The Swedish Council on Health Technology Assessment (SBU)	[Continuous subcutaneous glucose monitoring for diabetes]
2010	Committee for New Health Technology Assessment (CNHTA)	[Continuous local delivery of anesthesia to operative sites using an elastomeric infusion pump]
2015	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Continuous interstitial glucose monitoring (CGM) with real-time measurement devices in insulin-dependent diabetes mellitus]
2010	The Netherlands Organisation for Health Research and Development (ZonMw)	[Continuous flow registration for early detection of hepatic artery thrombosis after liver transplantation. Innovative technology reducing retransplantation rate?]
2009	Committee for New Health Technology Assessment (CNHTA)	[Continuous femoral nerve block]
2005	Andalusian Health Technology Assessment Area (AETSA)	[Continuous blood glucose monitoring system "GlucoWatch"]
2008	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Continuous anaesthetic infusion system at the surgical site]
2021	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Continuity of care]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Contaminants from the treatment of drinking water in the Autonomous Community of the Basque Country: Assessment of the risk and alternative treatments]
2011	Agenzia nazionale per i servizi sanitari regionali (Agenas)	[Consultation on the spread of tele-assistance for the management of the patient in post-stroke rehabilitation]
2008	Center for Medical Technology Assessment (CMT)	[Consequences appearing to family carers]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Consensus recommendations on post-traumatic brain injury (TBI) rehabilitation]
2021	Health Sciences Institute in Aragon (IACS)	[Congenital ventricular septal defect (VSD) treatment with percutaneous and periventricular insertion devices]
2008	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Congenital hypothyroidism: clinical practice guideline]
2010	Andalusian Health Technology Assessment Area (AETSA)	[Confocal microscopy in ophthalmology: Report summary of emergent technology]
2009	Basque Office for Health Technology Assessment (OSTEBA)	[Confidentiality of medical records. Analysis of the current situation and areas for improvement in their use and management]
2022	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Conductive intravesical chemohyperthermia with mitomycin in non-muscle invasive bladder cancer: review of guidelines and ongoing research]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Conditions for regional implementation of a national careprogramme anxiety disorders, based on the multidisciplinary evidence based guideline on anxiety disorders]